Atherosclerosis in Sjogren%26apos;s syndrome: evidence, possible mechanisms and knowledge gaps

作者：Valim V; Gerdts E; Jonsson R; Ferreira G A; Brokstad K A; Brun J G; Midtbo H Bergljot; Mydel P M

来源：Clinical and Experimental Rheumatology, 2016, 34(1): 133-142.

• Sjogren's syndrome
• subclinical cardiovascular disease
• atherosclerosis
• risk factors
• biomarkers

Inflammation has been associated with higher cardiovascular risk in rheumatic autoimmune diseases like rheumatoid arthritis (RA) and systemic lupus erythematosus. More recently, primary Sjogren's syndrome (pSS) was also demonstrated as an independent risk factor for cardiovascular disease, emerging as a new interesting model to study atherosclerosis in autoimmune diseases. Patients with pSS have a higher prevalence of developing traditional cardiovascular risk factors like hypertension and dyslipidaemia predisposing for endothelial dysfunction and premature atherosclerosis. However, the disease-specific mechanisms for premature atherosclerosis in pSS are not fully understood. The aim of this review was to critically analyse the current literature on cardiovascular risks in pSS and to discuss the traditional and disease-associated risk factors. We also suggest possible new mechanisms that should be explored in future research to close the current knowledge gaps on the association of pSS, premature atherosclerosis, and clinical cardiovascular disease.

• 出版日期2016-2